Participating Faculty: Pathways to Success: Utilizing Managed Care Models to Improve Clinical and Economic Outcomes in Diabetes

Faculty

Carrie McAdam Marx, PhD, RPh

Research Associate Professor

Department of Pharmacotherapy

Pharmacotherapy Outcomes Research Center

University of Utah

Salt Lake City, Utah

Mark E. Molitch, MD

Martha Leland Sherwin Professor of Endocrinology

Division of Endocrinology, Metabolism and Molecular Medicine

Northwestern University Feinberg School of Medicine

Chicago, Illinois

E. Albert Tzeel, MD, MHSA

National Medical Director

HumanaOne, Humana Inc.

Milwaukee, Wisconsin

Contributing Editorial Support

William Perlman, PhD, CMPP

Medical Director

Long Valley, NJ

Faculty Disclosures

These faculty have disclosed the following relevant commercial financial relationships or affiliations in the past 12 months.

Carrie McAdam Marx, PhD, RPh

Consultant/advisory board: GlaxoSmithKline, Novo Nordisk

Research grant: Bristol-Myers Squibb

Mark E. Molitch, MD

Consultant/advisory board: Abbott, Janssen, Lilly, Novartis, Novo Nordisk

Expert testimony: Janssen

Grants: Lilly, Novartis, Novo Nordisk, Sanofi

E. Albert Tzeel, MD, MHSA

Consultant/advisory board: Amylin Pharmaceuticals

Employment/stock ownership: Humana Inc

The American Journal of Managed Care

Publishing Staff—Jeff D. Prescott, PharmD, RPh; Kara Guarini, MS; and Ida Delmendo have no relevant financial relationships with commercial

interests to disclose.

PER and Pharmacy Times Office of Continuing Professional Education

Planning Staff—Judy V. Lum, MPA; Elena Beyzarov, PharmD; and Ann C. Lichti, CCMEP, have no relevant financial relationships with commercial interests to disclose.

PER and Pharmacy Times Office of Continuing Professional Education uses an anonymous peer review process to resolve conflicts of interest. The peer reviewers of this CME/CE activity have no relevant financial relationships with commercial interests to disclose.

This supplement to The American Journal of Managed Care provides an overview of the etiology and pathophysiology of type 2 diabetes mellitus (T2DM), including factors that contribute to suboptimal glucose control; explores current clinical practice guidelines and algorithms; evaluates new and emerging treatment strategies; and addresses managed care aspects of managing T2DM, including the impact of disease management programs on clinical measures, healthcare expenditures, and inpatient utilization.

Signed disclosures are on file at the office of The American Journal of Managed Care, Plainsboro, New Jersey.

Download PDF: Participating Faculty: Pathways to Success: Utilizing Managed Care Models to Improve Clinical and Economic Outcomes in Diabetes